Výsledky vyhledávání

Prospective pilot study to explore the melatonin level in brain tumor patients undergoing radiotherapy

Autor: Silvia Comas, Anna Esteve, Carmen Balana, Jorge Abad, Aida Muñoz-Ferrer, Jose Maria Hernandez, Giuseppe Lucente, C Panciroli, Salvador Villà

Publikováno v: Sleep and Breathing
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Purpose Our aim was to assess if the radiotherapy dose decreased the melatonin levels as well as the quality of life and sleep in brain tumor patients. Methods We performed a follow-up study on melatonin levels in saliva and its urinary metabolite su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf256ec40390d8f8796e12f1f650567
https://doi.org/10.1007/s11325-021-02365-5

Zobrazit plný text záznamu

4CPS-197 Monitoring of off-label use: analysis of prescriptions in the pharmacy’s antiblastic drugs unit

Autor: D Mazza, C Panciroli, G Mangoni, M Dall’aglio, Mla Medaglia, F Ruggiero, L Cavallo, F Corru, L Cervi

Publikováno v: Section 4: Clinical Pharmacy Services.

Background and importance In Italy, off-label (OL) drugs are regulated by 94/98 law: medication is used according to a therapeutic indication, dosage, frequency of administration, duration or route of administration different from approved indication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f123b7bea9f8afa0aa292770a6e7aed
https://doi.org/10.1136/ejhpharm-2020-eahpconf.298

Zobrazit plný text záznamu

1ISG-010 Introduction of rituximab biosimilar: an opportunity to improve health system efficiency?

Autor: Mla Medaglia, M Dall’aglio, D Mazza, F Ruggiero, G Mangoni, C Panciroli, L Cervi

Publikováno v: Section 1: Introductory Statements and Governance.

Background and importance The introduction of a biosimilar drug represents similar efficacy at a lower cost, providing savings without compromising patient treatment. Moreover, their quality is certified by regulatory agencies and high quality clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2f6384354141c1bafa1f307048a1941
https://doi.org/10.1136/ejhpharm-2020-eahpconf.10

Zobrazit plný text záznamu

P14.58 Efficacy and safety of lomustine versus fotemustine as first and second line treament in relapsed glioblastoma patients

Autor: C Fabregat, Maria Vieito, S. Del Barco, Ainhoa Hernandez, C Panciroli, Noelia Vilarino, C. Balana, D Garcia-Illescas, Montserrat Domenech, Carlos Mesia

Publikováno v: Neuro-Oncology. 23:ii49-ii49

BACKGROUND Glioblastoma (GB) is the most aggressive primary brain tumour. Despite the survival benefit associated with adjuvant therapy, most of patients (pts) relapse after initial therapy. Nitrosoureas (NU) are the standard treatment at relapse in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1dbbb799012d7aec51e13158e128bb80
https://doi.org/10.1093/neuonc/noab180.169

Zobrazit plný text záznamu

4CPS-074 Impact of antibiotic prophylaxis guidelines in obstetric and gynaecology surgery: a retrospective multi-centre study

Autor: C Panciroli, A Luoni, T Patrizia, SE Campbell Davies, MM Dragonetti, G Muserra, A Bignamini, P Minghetti

Publikováno v: Eur J Hosp Pharm

BACKGROUND: Antibiotic prophylaxis in obstetrics and gynaecology (O and G) surgery is known to be effective in reducing postoperative infections, hospitalisation and costs. In 2008, local guidelines on antibiotic prophylaxis in surgery were published

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7b5824987cfe9c3c9c093233d43361
https://europepmc.org/articles/PMC7535148/

Zobrazit plný text záznamu

4CPS-061 Antibiotic prophylaxis for preventing surgical wound infection after elective caesarean section: meta-analysis of clinical trials

Autor: C Panciroli, P Minghetti, A Luoni, A Bignamini

Publikováno v: Eur J Hosp Pharm

BACKGROUND: Surgical site infection (SSI) following caesarean section is the most important risk factor for postpartum morbidity, patient hospitalisation and its costs. Guidelines are recommended for the use of antibiotic prophylaxis for caesarean se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d7514c9831191d52f835fb556143ce
https://europepmc.org/articles/PMC7535440/

Zobrazit plný text záznamu

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

PurposeWe retrospectively examined the potential effect on overall survival (OS) of delaying radiotherapy to administer neoadjuvant therapy in unresected glioblastoma patients.Patients and methodsWe compared OS in 119 patients receiving neoadjuvant t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15211af401d36ccb79f3f7bbc83c4686
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1324

Zobrazit plný text záznamu

CP-227 Cost utility analyses of biological agents for refractory moderate to severe ulcerative colitis

Autor: MM Dragonetti, SE Campbell Davies, C Panciroli, G Polito, P Minghetti, C Inserra

Publikováno v: Clinical pharmacy.

Background Moderate to severe ulcerative colitis (UC), a chronic inflammatory disease affecting young adults, has a significant impact on patients’ quality of life. Different biological agents (BAs) have been approved for the treatment of patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bbf6f7c5609a03f9093739b38ac337c
https://doi.org/10.1136/ejhpharm-2017-000640.225

Zobrazit plný text záznamu

ECOG or Karnofsky Performance Status to Assess Functionality in Glioblastoma Patients Among Different Observers

Autor: C Panciroli, Laia Vilà, Giuseppe Lucente, Roser García, J.M. Velarde, Sira Domenech, S. Villà, Carmen Balana, Anna Estival

Publikováno v: Journal of Molecular Biomarkers & Diagnosis.

Purpose: Glioblastoma (GB) patients usually have symptoms that affect their functional status, and medical staff, as well as the patients and their caregivers, might have different perceptions about it. The performance status is important to establis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ba97b40f9beb92a38346cf26ed40f946
https://doi.org/10.4172/2155-9929.s2-032

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání